ArticleIntensive care medicine experimental2024

Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.

Bruno Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.